Works matching IS 00912700 AND DT 2024 AND VI 64 AND IP 11


Results: 13
    1

    Safety, Tolerability, and Pharmacokinetics of Single Doses of Exidavnemab (BAN0805), an Anti‐α‐Synuclein Antibody, in Healthy Western, Caucasian, Japanese, and Han Chinese Adults.

    Published in:
    Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1432, doi. 10.1002/jcph.6103
    By:
    • Boström, Emma;
    • Bachhav, Sagar S.;
    • Xiong, Hao;
    • Zadikoff, Cindy;
    • Li, Qingbo;
    • Cohen, Eric;
    • Dreher, Ingeborg;
    • Torrång, Anna;
    • Osswald, Gunilla;
    • Moge, Mikael;
    • Appelkvist, Paulina;
    • Fälting, Johanna;
    • Odergren, Tomas
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Issue Information.

    Published in:
    Journal of Clinical Pharmacology, 2024, v. 64, n. 11, p. 1337, doi. 10.1002/jcph.2085
    Publication type:
    Article